Cargando…
βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells
Non‐Small Cell Lung Carcinoma (NSCLC) remains a leading cause of cancer death. Resistance to therapy is a significant problem, highlighting the need to find new ways of sensitising tumour cells to therapeutic agents. βIII‐tubulin is associated with aggressive tumours and chemotherapy resistance in a...
Autores principales: | Brayford, Simon, Duly, Alastair, Teo, Wee Siang, Dwarte, Tanya, Gonzales‐Aloy, Estrella, Ma, Zerong, McVeigh, Laura, Failes, Timothy W., Arndt, Greg M., McCarroll, Joshua A., Kavallaris, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972117/ https://www.ncbi.nlm.nih.gov/pubmed/35946957 http://dx.doi.org/10.1002/cam4.5128 |
Ejemplares similares
-
βIII-Tubulin Gene Regulation in Health and Disease
por: Duly, Alastair M. P., et al.
Publicado: (2022) -
βIII-Tubulin Structural Domains Regulate Mitochondrial Network Architecture in an Isotype-Specific Manner
por: Parker, Amelia L., et al.
Publicado: (2022) -
An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
por: Parker, Amelia L., et al.
Publicado: (2017) -
β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells
por: Parker, Amelia L, et al.
Publicado: (2018) -
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
por: Phillip, Cornel Joseph, et al.
Publicado: (2013)